Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study

JP. Gonzalez-Rivas, JI. Mechanick, JP. Hernandez, MM. Infante-Garcia, I. Pavlovska, JR. Medina-Inojosa, S. Kunzova, R. Nieto-Martinez, J. Brož, L. Busetto, GA. Maranhao Neto, F. Lopez-Jimenez, J. Urbanová, GB. Stokin

. 2021 ; 7 (5) : 535-544. [pub] 20210505

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001767

Aims/Hypothesis: The need for understanding obesity as a chronic disease, its stigmatization, and the lack of actionability related to it demands a new approach. The adiposity-based chronic disease (ABCD) model is based on adiposity amount, distribution, and function, with a three stage complication-centric rather than a body mass index (BMI)-centric approach. The prevalence rates and associated risk factors are presented. Methods: In total, 2159 participants were randomly selected from Czechia. ABCD was established as BMI ≥ 25 kg/m2 or high body fat percent, or abdominal obesity and then categorized by their adiposity-based complications: Stage 0: none; Stage 1: mild/moderate; Stage 2: severe. Results: ABCD prevalence was 62.8%. Stage 0 was 2.3%; Stage 1 was 31.4%; Stage 2 was 29.1%. Comparing with other classifiers, participants in Stage 2 were more likely to have diabetes, hypertension, and metabolic syndrome than those with overweight, obesity, abdominal obesity, and increased fat mass. ABCD showed the highest sensitivity and specificity to detect participants with peripheral artery disease, increased intima media, and vascular disease. Conclusion/Interpretation: The ABCD model provides a more sensitive approach that facilitates the early detection and stratification of participants at risk compared to traditional classifiers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001767
003      
CZ-PrNML
005      
20251001105127.0
007      
ta
008      
220107s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/osp4.496 $2 doi
035    __
$a (PubMed)34631132
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gonzalez-Rivas, Juan P $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic $u Department of Global Health and Population Harvard TH Chan School of Public Health Harvard University Boston Massachusetts USA
245    10
$a Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study / $c JP. Gonzalez-Rivas, JI. Mechanick, JP. Hernandez, MM. Infante-Garcia, I. Pavlovska, JR. Medina-Inojosa, S. Kunzova, R. Nieto-Martinez, J. Brož, L. Busetto, GA. Maranhao Neto, F. Lopez-Jimenez, J. Urbanová, GB. Stokin
520    9_
$a Aims/Hypothesis: The need for understanding obesity as a chronic disease, its stigmatization, and the lack of actionability related to it demands a new approach. The adiposity-based chronic disease (ABCD) model is based on adiposity amount, distribution, and function, with a three stage complication-centric rather than a body mass index (BMI)-centric approach. The prevalence rates and associated risk factors are presented. Methods: In total, 2159 participants were randomly selected from Czechia. ABCD was established as BMI ≥ 25 kg/m2 or high body fat percent, or abdominal obesity and then categorized by their adiposity-based complications: Stage 0: none; Stage 1: mild/moderate; Stage 2: severe. Results: ABCD prevalence was 62.8%. Stage 0 was 2.3%; Stage 1 was 31.4%; Stage 2 was 29.1%. Comparing with other classifiers, participants in Stage 2 were more likely to have diabetes, hypertension, and metabolic syndrome than those with overweight, obesity, abdominal obesity, and increased fat mass. ABCD showed the highest sensitivity and specificity to detect participants with peripheral artery disease, increased intima media, and vascular disease. Conclusion/Interpretation: The ABCD model provides a more sensitive approach that facilitates the early detection and stratification of participants at risk compared to traditional classifiers.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mechanick, Jeffrey I $u The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease Icahn School of Medicine at Mount Sinai New York New York USA
700    1_
$a Hernandez, José Pantaleón $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic
700    1_
$a Infante-Garcia, María M $u Foundation for Clinic, Public Health, and Epidemiological Research of Venezuela (FISPEVEN) Caracas Venezuela
700    1_
$a Pavlovska, Iuliia $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic $u Department of Public Health Faculty of Medicine Masaryk University Brno Czech Republic $7 xx0336002
700    1_
$a Medina-Inojosa, José R $u Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA
700    1_
$a Kunzova, Sarka $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic
700    1_
$a Nieto-Martinez, Ramfis $u Department of Global Health and Population Harvard TH Chan School of Public Health Harvard University Boston Massachusetts USA $u LifeDoc Diabetes and Obesity Clinic Memphis Tennessee USA
700    1_
$a Brož, Jan $u Department of Internal Medicine Second Faculty of Medicine Charles University Praha Praha Czech Republic
700    1_
$a Busetto, Luca $u European Association for the Study of Obesity (EASO) Teddington Middlesex UK $u Department of Medicine University of Padova Padova Italy
700    1_
$a Maranhao Neto, Geraldo A $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic
700    1_
$a Lopez-Jimenez, Francisco $u Department of Medicine 2 Third Faculty of Medicine Charles University and Královské Vinohrady University Hospital Prague Czech Republic
700    1_
$a Urbanová, Jana $u Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA
700    1_
$a Stokin, Gorazd B $u International Clinical Research Center (ICRC) St Anne's University Hospital (FNUSA) Brno Brno Czech Republic
773    0_
$w MED00208619 $t Obesity science & practice $x 2055-2238 $g Roč. 7, č. 5 (2021), s. 535-544
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34631132 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20251001105114 $b ABA008
999    __
$a ind $b bmc $g 1745610 $s 1152914
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 7 $c 5 $d 535-544 $e 20210505 $i 2055-2238 $m Obesity science & practice $n Obes. sci. pract. $x MED00208619
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace